PRVA - Privia Health Group Non-GAAP EPS of $0.12 beats by $0.03 revenue of $313.8M beats by $19.2M; updated FY22 guidance

Privia Health Group press release (NASDAQ:PRVA): Q1 Non-GAAP EPS of $0.12 beats by $0.03. Revenue of $313.8M (+46.9% Y/Y) beats by $19.2M. Adjusted EBITDA for the first quarter of 2022 was $14.8 million, compared to $9.9 million for the same period in 2021 (+48.8%). Privia Health updated its full-year 2022 guidance, as follows: GAAP Revenue of $1,225M - $1,300M vs. consensus of $1.26B; Adjusted EBITDA of $52M - $56M. Capital expenditures expected to be less than $1 million in full-year 2022.

For further details see:

Privia Health Group Non-GAAP EPS of $0.12 beats by $0.03, revenue of $313.8M beats by $19.2M; updated FY22 guidance